HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Doctors with red ribbon | Image credit: michaeljung - stock.adobe.com
End of PEPFAR Funding Could Lead to Tens of Thousands of HIV Deaths

July 8th 2025

Countries in sub-Saharan Africa could see thousands of deaths from HIV due to cuts to the US President’s Emergency Plan for AIDS Relief (PEPFAR), underscoring the necessity of reinstating the program.

Black man with HIV | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com
Preference for Long-Acting vs On-Demand PrEP Seen in Black Men in the US

July 3rd 2025

PrEP | Image credit: alimyakubov - stock.adobe.com
Higher Levels of PrEP Use Associated With Reduction in HIV Diagnoses

June 30th 2025

PrEP | Image credit: Bowonpat - stock.adobe.com
Researchers Estimate PrEP Needed in the US Across Multiple Subgroups

June 24th 2025

Colleen Kelley, MD, MPH
Accessibility Important After FDA Approves Lenacapavir for PrEP: Q&A With Colleen Kelley, MD, MPH

June 20th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
July 10th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
July 10th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Group Intervention | Image credit: Monkey Business - stock.adobe.com
April 19th 2024

Peer Interventions Beneficial to HIV Testing Rates Among Immigrants

Julia Bonavitacola
HIV testing uptake was improved in immigrants after peer interventions with multiple strategies were implemented.
Mother holding newborn baby | Image credit: kieferpix - stock.adobe.com
April 11th 2024

Adverse Perinatal Outcomes Associated With Maternal HIV Infection

Julia Bonavitacola
Pregnant women with HIV need targeted interventions and improved care to combat these adverse outcomes.
Homeless man | Image credit: FollowTheFlow
April 8th 2024

Challenges, Adaption Needed in Conducting Research for Homeless Youth Living With HIV

Julia Bonavitacola
HIV testing, treatment, and intervention session delivery were among some areas that saw challenges in properly addressing youth experiencing homelessness during an HIV prevention trial.
Jail | Image credit: karenfoleyphoto - stock.adobe.com
April 2nd 2024

PrEP Uptake, HIV Care Continuum Have Improved for Adults in Federal Custody

Julia Bonavitacola
A new study found that adults in custody of the Federal Bureau of Prisons have seen improved pre-exposure prophylaxis (PrEP) initiation and sustained treatment uptake for HIV.
Mobile phone technology | Image credit: sdecoret - stock.adobe.com
April 1st 2024

mHealth Intervention Serves as Potential Tool for PrEP Uptake in MSM

Julia Bonavitacola
Men who have sex with men (MSM) who primarily spoke Spanish and transgender women who spoke either English or Spanish had positive experiences with a mobile health (mHealth) intervention.
HIV Awareness | Image credit: fizkes - stock.adobe.com
March 26th 2024

Late Presentation of HIV Most Common in Older Patients

Julia Bonavitacola
Older patients and patients of sub-Saharan African origin were at an increased risk of late presentation of advanced HIV.
Medical Residents | Image credit: Flamingo Images - stock.adobe.com
March 22nd 2024

PrEP Curriculum Varies in Family Medicine Clerkship

Julia Bonavitacola
Family medicine clerkships in medical school were found to have varying degrees of curriculum dedicated to pre-exposure prophylaxis (PrEP) based on the expertise or judgement of the faculty.
Caregiver with Patient | Image credit: interstid - stock.adobe.com
March 21st 2024

Caregivers of Patients With HIV Have Both Positive, Negative Experiences

Julia Bonavitacola
Although caregivers of patients living with HIV are significantly burdened with psychological and physical stresses, some described positive aspects of caregiving.
what we're reading logo
March 20th 2024

What We’re Reading: Global AIDS Program Renewed; Fetal Tissue Research Importance; Health Care Hacking Defenses Still Fail

AJMC Staff
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
HIV | Image credit: artegorov3@gmail - stock.adobe.com
March 15th 2024

Self-Testing for HIV Could Promote Risk Behaviors in MSM

Julia Bonavitacola
Men who have sex with men (MSM) were found to engage in more risk behaviors when self-testing for HIV.
Man sitting with head in hands | Image credit: ARAMYAN - stock.adobe.com
March 6th 2024

Better Family Functioning Associated With Lower Depressive Symptoms in Men With HIV

Julia Bonavitacola
Men who have sex with men who are living with HIV tend to have fewer depressive symptoms if they report better family functioning.
WWR banner
March 6th 2024

What We’re Reading: COVID-19 Test Program End; Ozempic Lowers Liver Disease Risk; Amniotic Fluid Cells, Organ Growth

AJMC Staff
The US government’s program to send free COVID-19 tests is ending later this week; a new study found that Ozempic (semaglutide) may lower liver disease risks in people living with HIV; scientists use cells from amniotic fluid to grow miniature organs.
Nurse talking to patient | Image credit: rocketclips - stock.adobe.com
March 5th 2024

Blood Pressure, Cholesterol Lowered in People Living With HIV Using Nurse-Led Strategy

Julia Bonavitacola
A nurse-led strategy for people living with HIV was able to reduce both blood pressure and cholesterol in a 12-month period.
HIV Virus | Image credit: RAJCREATIONZS - stock.adobe.com
February 28th 2024

Patients With HIV, PH Had Higher Burden of Comorbidities

Julia Bonavitacola
The higher burden of comorbidities in patients with both HIV and pulmonary hypertension (PH) led to worse outcomes, including mortality.
Blue FDA Approved stamp on white surface | Image credit: Olivier Le Moal - stock.adobe.com
February 26th 2024

Bictegravir Receives Expanded Indication by FDA to Treat HIV

Julia Bonavitacola
Patients with HIV who have suppressed viral loads and pre-existing resistance will be able to use bictegravir with this FDA approval.
Human brain | Image credit: Siarhei - stock.adobe.com
February 19th 2024

Adults With Intellectual, Developmental Disabilities at Risk for Disparities in HIV

Julia Bonavitacola
Different levels of risk for HIV exist in the different subtypes of intellectual and developmental disabilities.
Close-up of vaccine | Image credit: weyo - stock.adobe.com
February 15th 2024

Vaccine Confidence in Pregnant Women Living With HIV Requires Further Study

Julia Bonavitacola
Pregnant women who are living with HIV are underrepresented in studies on the efficacy of vaccines, leading to difficult policy decisions for this population.
Woman holding HIV ribbon | Image credit: fizkes - stock.adobe.com
February 6th 2024

Continuity of HIV Care Preserved During Pandemic Through Telemedicine, Despite Lack of In-Person Care

Julia Bonavitacola
Strategies used during the COVID-19 pandemic to ensure continuity of care in people living with HIV can be used as a paradigm of adaptability during unexpected crises.
Bottle of prescription opioids | Image credit: Kimberly Boyles - stock.adobe.com
February 2nd 2024

OUD Stable Over Time in People Living With HIV, Chronic Pain

Julia Bonavitacola
Although rates of opioid use disorder (OUD) are higher than previous estimates, OUD was relatively stable or decreasing over time in patients with HIV.
Man with face in hands | Image credit: ARAMYAN - stock.adobe.com
January 23rd 2024

Internalized HIV Stigma, Depressive Symptoms Linked in People Living With HIV

Julia Bonavitacola
People living with HIV reported feeling inferiority due to HIV and gloomy feelings during the COVID-19 pandemic, as researchers linked internalized HIV stigma to depressive symptoms.
Machine learning | Image credit: WrightStudio - stock.adobe.com
January 23rd 2024

Machine Learning Effective in Predicting Hospital Stay, Prolonged Hospitalization in People Living With HIV

Julia Bonavitacola
Separate machine learning models were able to effectively predict both the length of hospital stay and the risk of prolonged hospitalization in people living with HIV.
Medical syringe with vaccine | Image credit: weyo - stock.adobe.com
January 17th 2024

Vaccination for Hepatitis A Low in People Living With HIV

Julia Bonavitacola
Patients living with HIV had a lower uptake of hepatitis A virus vaccination despite it being recommended for this population.
HIV Virus | Image credit: artegorov3@gmail - stock.adobe.com
January 11th 2024

Women Living With HIV Could Have Tooth Loss After Menopause

Julia Bonavitacola
The deterioration of bones could contribute to the loss of teeth in women who are postmenopausal and living with HIV.
breast cancer awareness ribbon | Image credit: NaMong Productions - stock.adobe.com
December 25th 2023

Patients With Breast Cancer, HIV More Likely to Experience Suboptimal Adjuvant Chemotherapy Delivery

Brooke McCormick
The researchers noted the need for strategies to better support women living with HIV with breast cancer during toxic therapies to improve outcomes among this growing population.
Top 5 Most-Read HIV Articles of 2023
December 20th 2023

Top 5 Most-Read HIV Articles of 2023

Julia Bonavitacola
The top-read topics in HIV for 2023 included dried blood tests for HIV, people with HIV facing stigmas, and vitamin D supplementation in women with HIV.
Top 5 Most-Read News Content of 2023
December 18th 2023

Top 5 Most-Read News Content of 2023

Julia Bonavitacola
The top 5 most-read news content for 2023 featured COVID-19 vaccination uptake and its relation to HIV viral suppression, those more likely to get vitamin D supplements, and recurrence of Clostridioides difficile infection.
Patient with HIV | Image credit: fizkes - stock.adobe.com
December 13th 2023

All-Cause Mortality of Chinese Patients With HIV Declined During Past Decade, Study Says

Brooke McCormick
From 2013 to 2022, the all-cause mortality rate among patients with HIV in China declined from 5.4% to 2.7%.
newborn | Image credit: Anatta_Tan - stock.adobe.com
December 11th 2023

HIV-Infected Infants Treated Within Hours of Birth Attain, Sustain Undetectable Virus

Kenneth Bender, PharmD, MA
Infants with HIV could be spared from requiring lifetime antiretroviral (ART) if treated within hours of birth to disrupt formation of HIV viral reservoirs.
what we're reading
December 7th 2023

What We’re Reading: AIDS Relief Negotiations; Menthol Cigarette Ban Delayed; At-Home Flu, COVID-19 Testing

AJMC Staff
Negotiations to extend US global HIV/AIDS relief work are deadlocked; the Biden administration delayed its rule on the proposed menthol cigarette ban until March 2024 after lobbying by civil rights groups; federal agencies have partnered with a digital health company to create an at-home test-to-treat program for flu and COVID-19.
pediatric patient
December 6th 2023

CDC Reports Higher Mortality, Treatment Interruption Rates Among Children With HIV Receiving ART vs Older Patients

Brooke McCormick
The researchers suggested prioritizing and optimizing HIV and general health services for children younger than age 5 living with HIV and receiving ART to help address their disproportionately poorer outcomes.
<123456789
...
33>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo